No Data
LIFETECH SCI: INTERIM REPORT 2024
Express News | China Securities Co.,Ltd. recommends focusing on investment opportunities in the medical device sector, and focusing on the direction and individual stocks with strong performance certainty.
Press Release: LifeTech Scientific Corporation Announced 2024 Interim Results: International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%
LifeTech Scientific H1 Profit Declines 6.6%
lifetech sci (01302) announced its interim results, with shareholders' net profit attributable to around 0.206 billion yuan, a decrease of about 6.6% year-on-year.
Lifetech Sci (01302) released its interim performance for the six months ended June 30, 2024, with a turnover of approximately RMB...
Performance: Lifetech Sci (01302.HK) half-year net profit of 0.206 billion RMB, down 6.6%, no dividend.
Lifetech Sci (01302.HK) announced its interim performance as of the end of June this year, with revenue of 0.653 billion yuan (the same below), a 2.1% increase year-on-year. The net profit was 0.206 billion yuan, a 6.6% decrease year-on-year; earnings per share were 4.6 cents. No dividend is declared.
No Data
No Data